Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126617722 | 12661772 | 2 | F | 20141120 | 20160808 | 20160817 | 20160818 | EXP | US-BAYER-2015-375441 | BAYER | 72.00 | YR | E | F | Y | 0.00000 | 20160818 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126617722 | 12661772 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | UNK | U | 0 | FILM-COATED TABLET | ||||||||
| 126617722 | 12661772 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | U | 0 | 20 | MG | FILM-COATED TABLET | ||||||
| 126617722 | 12661772 | 3 | SS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Unknown | UNK UNK, QD | U | 0 | QD | ||||||||
| 126617722 | 12661772 | 4 | PS | NAPROXEN SODIUM ({= 220 mg) | NAPROXEN SODIUM | 1 | Unknown | UNK | U | 20204 | |||||||||
| 126617722 | 12661772 | 5 | SS | LORCET | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | UNK | 0 | ||||||||||
| 126617722 | 12661772 | 6 | SS | WARFARIN | WARFARIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126617722 | 12661772 | 7 | SS | AGGRENOX | ASPIRINDIPYRIDAMOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 126617722 | 12661772 | 8 | SS | MIRADON | ANISINDIONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126617722 | 12661772 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126617722 | 12661772 | 1 | Pulmonary embolism |
| 126617722 | 12661772 | 2 | Embolism venous |
| 126617722 | 12661772 | 3 | Product used for unknown indication |
| 126617722 | 12661772 | 4 | Product used for unknown indication |
| 126617722 | 12661772 | 5 | Product used for unknown indication |
| 126617722 | 12661772 | 6 | Pulmonary thrombosis |
| 126617722 | 12661772 | 7 | Product used for unknown indication |
| 126617722 | 12661772 | 8 | Product used for unknown indication |
| 126617722 | 12661772 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126617722 | 12661772 | HO |
| 126617722 | 12661772 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126617722 | 12661772 | Anaemia | |
| 126617722 | 12661772 | Internal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126617722 | 12661772 | 2 | 20150219 | 20150418 | 0 | |
| 126617722 | 12661772 | 6 | 2015 | 0 |